Harmless maximum levels
Three years ago, Health Canada commissioned a team of experts to examine cannabidiol and its effects on the body to decide whether it could be sold by mainstream shops without requiring a prescription and no longer be available only in adult-use cannabis shops. The conclusion of their tests was that CBD is a safe and well-tolerated substance for short-term use (30 days maximum), with daily doses ranging from 20 to 200 milligrams maximum.
The group of scientists involved in this study noted the desire of the Canadian population to have access to health products containing cannabis without the supervision of a practitioner, be it a doctor or a nurse. However, the experts also specifically requested that warning labels be placed on the products.
They also stated that with these precautions, even with a maximum dose of 200 mg/day, the maximum amount of THC then absorbed into the blood and present in the brain would potentially not be high enough to cause significant psychotropic effects in the majority of users.
An open door for a new CBD market?
The final decision on whether CBD can be sold in retail outlets open to the public is now up to Health Canada. However, there is no deadline for the agency to reach a verdict and act on it...
It should be noted that this recommendation could open up a significant new market for cannabidiol. Indeed, until now, almost all Canadian producers have focused on producing cannabis and THC strains for older consumers, without being able to offer real new products to those who would have preferred less potent and more balanced strains or simply CBD-based "wellness" products.
As such, some brands are already planning to take advantage of this niche market by offering low THC products through the Société Québécoise du Cannabis (SQDC).